The Quantellect read.As of Nov 19, 2026, 4 active firms cover Braskem SA Class A: 0 rate it Buy or better, 2 sit at Neutral, and 2 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $1.50 to $1.50, so the covering firms are broadly aligned. The average target of $1.50 sits 73% above the current $0.87. Sentiment has cooled somewhat, with Sell ratings rising from 1 to 2 over recent months. On the fundamentals, the Street sees revenue growth near 13% this year and 4% next.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 active firms
Neutral
Strong Buy00%
Buy00%
Neutral250%
Sell250%
Strong Sell00%
Based on 4 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$1.50
+72.6% upside
Average target across 2 active firms as of Nov 19, 2026 vs $0.87 current
Highest Target$1.50
Average Target$1.50
Lowest Target$1.50
Detailed analyst forecasts for BAK
Showing 1–4 of 4 named analysts shown · 4 active firms in the rating projection
As of Nov 19, 2026, 0 of 4 active firms rate BAK a Buy (2 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BAK EPS & revenue forecast
EPS · NEXT QUARTER
—
Range — – — · 0 analysts
Next period, 0 analysts expect Braskem SA Class A to earn — a share (range — – —), versus — a year earlier. Full-year consensus is $0.53, growing to $-1.08 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 0 analysts · +30% YoY
Revenue is expected to reach $0 (range $0 – $0), +30.0% year-over-year. Full-year consensus is $74.4B, rising to $79.8B next year.
Top analysts covering Braskem SA Class A
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BAK.
#1
TV
Tasso Vasconcellos
UBS
Sell
$1.50+72.6% to target
Coverage
—
+ Follow
#2
SP
Sriharsha Pappu
HSBC
Neutral
$1.50+72.6% to target
Coverage
—
+ Follow
#3
GB
Gabriel Barra
Citigroup
Sell
No targeton BAK
Coverage
—
+ Follow
#4
VF
Vicente Falanga
Bradesco
Sell
$1.50+72.6% to target
Coverage
—
+ Follow
#5
RR
Rodrigo Reis de Almeida
BTG Pactual
Sell
$2.80+222.1% to target
Coverage
—
+ Follow
BAK stock forecast FAQ
What is BAK's average 12-month price target?+
The 2 active firms with a live target average $1.50 for Braskem SA Class A over the next 12 months, ranging from a $1.50 high to a $1.50 low, as of Nov 19, 2026.
Is BAK stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 4 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 2 rate it Neutral, and 2 rate it Sell or Strong Sell.
How many active Wall Street firms cover BAK?+
4 active firms have a recognized rating on Braskem SA Class A as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BAK?+
Among analysts who currently cover BAK, Tasso Vasconcellos of UBS has the strongest overall Quantellect track record. Their current call is Sell with a $1.50 target.
What is Braskem SA Class A's projected EPS for next quarter?+
The consensus estimate is — per share (range — – —) across 0 analysts. Full-year EPS is projected at $0.53, rising to $-1.08 the following year.
How much revenue is Braskem SA Class A expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $74.4B, growing to $79.8B next year.
Have analysts been upgrading or downgrading BAK lately?+
As of Nov 19, 2026, 0 of 4 active firms rate BAK a Buy (2 Neutral, 2 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BAK calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.